Inventor · Hexham, GB

Ian Robert Hardcastle

19Patents
6h-index
54Co-inventors
69Inventor score

Filing activity: Sep 30, 1994 → Feb 1, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US5604213A 17-substituted steroids useful in cancer treatment Chemistry; Metallurgy 55 Expired
US5618807A Method for preparing 17-substituted steroids useful in cancer treatment Chemistry; Metallurgy 13 Expired
US8618158B2 Therapeutic agents Chemistry; Metallurgy 10 Active
US8258175B2 Isoindolin-1-one derivatives Chemistry; Metallurgy 10 Active
US9358222B2 Therapeutic agents Chemistry; Metallurgy 9 Active
US10544132B2 Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity Chemistry; Metallurgy 7 Active
US7402607B2 DNA-PK inhibitors Chemistry; Metallurgy 6 Expired
US10526311B2 Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity Chemistry; Metallurgy 6 Active
US10414726B2 Therapeutic agents Chemistry; Metallurgy 6 Active
US10981898B2 Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity Chemistry; Metallurgy 4 Active
US7696203B2 DNA-PK inhibitors Chemistry; Metallurgy 3 Active
US5589500A Substituted 1,1,2-triphenylbutenes and their use in the treatment of cancer Chemistry; Metallurgy 3 Expired
US7674823B2 DNA-PK inhibitors Chemistry; Metallurgy 2 Active
US11261171B1 Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity Chemistry; Metallurgy 2 Active
US7105518B2 Thiopyrane-4-ones as DNA protein kinase inhibitors Human Necessities 2 Expired
US10344017B2 Pyrrolcarboxamide derivatives for the inhibition of ERK5 Chemistry; Metallurgy 1 Active
US7226918B2 DNA-PK inhibitors Chemistry; Metallurgy 1 Expired
US7732483B2 DNA-PK inhibitors Chemistry; Metallurgy 0 Active
US12071429B2 Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.